You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Personalized vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in San Diego (personalized vaccine, Pembrolizumab)

Active, not recruiting
  • Advanced Cancer
  • San Diego, California
    UCSD Medical Center
Sep 20, 2022

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

COVID-19, Vaccine Hesitancy Trial in Seattle (Vaccine Norms Feedback, Alcohol Norms Feedback)

Recruiting
  • COVID-19
  • Vaccine Hesitancy
  • Vaccine Norms Feedback
  • Alcohol Norms Feedback
  • Seattle, Washington
    University of Washington
Mar 14, 2023

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

Not yet recruiting
  • Unmethylated Glioblastoma
  • Personalized Neoantigen DNA vaccine
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 14, 2023

NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose

Recruiting
  • Non-small Cell Lung Cancer
  • Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
  • Low dose cyclophosphamide
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jan 17, 2022

Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)

Recruiting
  • Smoldering Plasma Cell Myeloma
  • Biopsy Specimen Radiography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 12, 2021

Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

Completed
  • Urothelial/Bladder Cancer, Nos
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 7, 2022

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Cervical Cancer, Anal Cancer, Penile Cancer Trial in College Park (Personalized Chatbot Intervention, Non-Personalized Chatbot

Recruiting
  • Cervical Cancer
  • +2 more
  • Personalized Chatbot Intervention
  • +2 more
  • College Park, Maryland
    University of Maryland, College Park (Online Survey-Experiment)
Jul 17, 2023

Malignant Glioma, Recurrent Glioma Trial in Beijing (personalized vaccine)

Recruiting
  • Malignant Glioma
  • Recurrent Glioma
  • personalized vaccine
  • Beijing, Beijing, China
    Xuanwu Hospital, Capital Medical University
Jun 26, 2021

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

Not yet recruiting
  • Posto Perative Hepatocellular Carcinoma
  • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
  • (no location specified)
Feb 27, 2023

Brain Cancer, Tumor Metastases Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Brain Cancer
  • Neoplasm Metastases
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Cancer of Gastrointestinal Tract Trial in La Jolla (personalized vaccine, Ipilimumab, Nivolumab)

Not yet recruiting
  • Cancer of Gastrointestinal Tract
  • personalized vaccine
  • +2 more
  • La Jolla, California
    University of California, San Diego
Nov 29, 2021

Glioblastoma Trial in Saint Louis (NeoVax, Nivolumab, Ipilimumab)

Terminated
  • Glioblastoma
  • NeoVax
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2021

Hepatocellular Carcinoma Trial in Cairo (Peptide cancer vaccine)

Recruiting
  • Hepatocellular Carcinoma
  • Peptide cancer vaccine
  • Cairo, Egypt
    Faculty of Medicine Ain Shams Research Institute- Clinical Resea
Aug 10, 2022

Solid Tumor Trial in Beijing (Personalized neoantigen tumor vaccine)

Not yet recruiting
  • Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 28, 2022

Non Small Cell Lung Cancer Trial in Amsterdam, Groningen, Rotterdam (FRAME-001 personalized vaccine)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • FRAME-001 personalized vaccine
  • Amsterdam, Netherlands
  • +2 more
Aug 9, 2021

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Pancreatic Tumor Trial in Shanghai (Personalized neoantigen vaccine)

Recruiting
  • Pancreatic Tumor
  • Personalized neoantigen vaccine
  • Shanghai, Shanghai, China
    Changhai Hospital
Mar 8, 2022